Search
for
Sort by
Research 451–480 of 1000+
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- The Mechanism and Research Progress of Skin Microbiota in Pathogenesis of Acne
- Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
- 1H NMR-based lipidomics of rodent fur: species-specific lipid profiles and SCD1 inhibitor-related dermal toxicity
- Efficacy of 0.1% adapalene in a non-inflammatory Kyoto Rhino Rat acne model
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Isolated Human Skin Glands and Appendages: Models for Cystic Fibrosis, Acne Vulgaris, Alopecia and Hidradenitis Suppurativa
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Analysis of hidradenitis suppurativa–linked mutations in four genes and the effects of PSEN1-P242LfsX11 on cytokine and chemokine expression in macrophages
- https://researchopenworld.com/genetics-of-hidradenitis-suppurativa/#
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- ESCITALOPRAM
- Actions of isotretinoin and etretinate on the pilosebaceous unit
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- Sorafenib-Associated Facial Acneiform Eruption
- Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease
- Aberrant Wnt Signaling Induces Comedo-Like Changes in the Murine Upper Hair Follicle
- Apoptosis in Hair and Skin: A Review
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Repurposing Metformin for Dermatological Use: Mechanisms, Evidence, and Clinical Perspectives
- Saw palmetto extract: A dermatologist's perspective
- A Systematic Review of Spironolactone Nano-Formulations for Topical Treatment of Skin Hyperandrogenic Disorders and Chronic Wounds
- Emerging Trends and Focus in Human Skin Microbiome Over the Last Decade: A Bibliometric Analysis and Literature Review
- The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Altered Skin Permeation of Finasteride Using Clove Oil, Urea, and Lyophilized Powder of Grape Seed Extract